OpenURL Connection Search

Select item for more details and to access through your institution.

Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 6, p. 1260, doi. 10.1093/jac/dkp348
By:
- Bickel, M.;
- Bodtländer, A.;
- Knecht, G. K.;
- Stephan, C.;
- Von Hentig, N.;
- Kurowski, M.;
- Gute, P.;
- Klauke, S.;
- Lutz, T.
Publication type:
Article
Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48-week data from a German outpatient cohort.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P28, doi. 10.1186/1758-2652-13-S4-P28
By:
- Lunzen, J;
- Gorriahn, D;
- Wünsche, T;
- Dupke, S;
- Gute, P;
- Schewe, CK;
- Ranneberg, B
Publication type:
Article
Efficacy and tolerability of darunavir/r 600/100 mg bid in treatment-experienced patients: 48- week data from a German outpatient cohort.
Published in:
2010
By:
- van Lunzen, J.;
- Gorriahn, D.;
- Wünsche, T.;
- Dupke, S.;
- Gute, P.;
- Schewe, C. K.;
- Ranneberg, B.
Publication type:
Abstract
Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Published in:
HIV Medicine, 2013, v. 14, n. 10, p. 633, doi. 10.1111/hiv.12072
By:
- Bickel, M;
- Khaykin, P;
- Stephan, C;
- Schmidt, K;
- Buettner, M;
- Amann, K;
- Lutz, T;
- Gute, P;
- Haberl, A;
- Geiger, H;
- Brodt, HR;
- Jung, O
Publication type:
Article
End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years.
Published in:
HIV Medicine, 2013, v. 14, n. 3, p. 127, doi. 10.1111/j.1468-1293.2012.01045.x
By:
- Bickel, M;
- Marben, W;
- Betz, C;
- Khaykin, P;
- Stephan, C;
- Gute, P;
- Haberl, A;
- Knecht, G;
- Wolf, T;
- Brodt, HR;
- Geiger, H;
- Herrmann, E;
- Jung, O
Publication type:
Article
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results.
Published in:
HIV Medicine, 2002, v. 3, n. 4, p. 277, doi. 10.1046/j.1468-1293.2002.00123.x
By:
- Voigt, E;
- Wickesberg, A;
- Wasmuth, J-C;
- Gute, P;
- Locher, L;
- Salzberger, B;
- Wöhrmann, A;
- Adam, A;
- Weitner, L;
- Rockstroh, JK
Publication type:
Article
A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users.
Published in:
HIV Medicine, 2000, v. 1, n. 3, p. 162, doi. 10.1046/j.1468-1293.2000.00020.x
By:
- Staszewski, S;
- Haberl, A;
- Carlebach, A;
- Rottmann, C;
- Miller, V;
- Gute, P
Publication type:
Article
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis.
Published in:
Medical Microbiology & Immunology, 2014, v. 203, n. 6, p. 409, doi. 10.1007/s00430-014-0350-5
By:
- Wolf, T.;
- Fuß, B.;
- Khaykin, P.;
- Berger, A.;
- Knecht, G.;
- Gute, P.;
- Brodt, H.;
- Goepel, S.;
- Bickel, M.;
- Stuermer, M.;
- Stephan, C.
Publication type:
Article

Found: 8